Scarica l'app Stockscreener
2.65
1.85%
-0.05
Dopo l'orario di chiusura:
2.69
0.04
+1.51%
Precedente Chiudi:
$2.70
Aprire:
$2.69
Volume 24 ore:
973.29K
Relative Volume:
0.73
Capitalizzazione di mercato:
$175.23M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-2.2458
EPS:
-1.18
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
-15.06%
1M Prestazione:
-2.93%
6M Prestazione:
-39.50%
1 anno Prestazione:
+157.28%
Intervallo 1D:
$2.61
$2.745
Intervallo di 1 settimana:
$2.61
$3.1673
Portata 52W:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Nome
Neuronetics Inc
Settore
Industria
Telefono
877-600-7555
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Confronta STIM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
2.65 | 178.54M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2018-07-24 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Neuronetics Inc Borsa (STIM) Ultime notizie
Real time alert setup for Neuronetics Inc. performanceEntry Point & Long-Term Safe Investment Plans - newser.com
Is Neuronetics Inc. (NRC) stock a buy before earnings results2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
What does recent volatility data suggest for Neuronetics Inc.Short Setup & AI Powered Market Trend Analysis - newser.com
Will Neuronetics Inc. bounce back from current supportTrade Volume Report & Long-Term Safe Investment Ideas - newser.com
Will Neuronetics Inc. continue its uptrendWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Sentiment analysis tools applied to Neuronetics Inc.July 2025 Patterns & AI Forecast Swing Trade Picks - newser.com
Will Neuronetics Inc. stock maintain dividend yieldWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Analyzing net buyer seller activity in Neuronetics Inc.July 2025 Institutional & Verified Trade Idea Suggestions - newser.com
Is Neuronetics Inc. stock a top momentum playJuly 2025 Earnings & Trade Opportunity Analysis - newser.com
Detecting support and resistance levels for Neuronetics Inc.Profit Target & Low Risk Entry Point Guides - newser.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Neuronetics (NASDAQ: STIM) grants 38,850 RSUs to 12 employees under Nasdaq 5635(c)(4) - Stock Titan
Exit strategy if you’re trapped in Neuronetics Inc.2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
Can trapped investors hope for a rebound in Neuronetics Inc.Volume Spike & Risk Managed Trade Strategies - newser.com
Neuronetics Inc. stock trend forecast2025 Market Overview & Fast Moving Market Watchlists - newser.com
Will Neuronetics Inc. stock maintain growth storyJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
Is Neuronetics Inc. stock attractive for long term wealth buildingRecession Risk & Target Return Focused Picks - newser.com
Neuronetics signs exclusive TMS device agreement with Elite DNA - Investing.com
Neuronetics signs exclusive TMS device agreement with Elite DNA By Investing.com - Investing.com Canada
Neuronetics (STIM) Secures Exclusive Deal with Elite DNA Behavio - GuruFocus
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - The Manila Times
Neuronetics (NASDAQ: STIM) sole TMS provider to Elite DNA’s 30+ sites in 3‑year pact - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics (STIM) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Is Neuronetics Inc. stock positioned well for digital economyJuly 2025 Decliners & Expert Verified Movement Alerts - fcp.pa.gov.br
Is the Valuation of Mauria Udyog Limited Sustainable P E and PEG BreakdownReal-Time Stock Alerts & Free High Yield Market Plays - earlytimes.in
Neuronetics Inc Azioni (STIM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):